Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial

2021 ◽  
Author(s):  
Thomas Powles ◽  
Michael B. Atkins ◽  
Bernard Escudier ◽  
Robert J. Motzer ◽  
Brian I. Rini ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Disease Progression ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Phase 2 Clinical Trial ◽  
Randomized Phase 2

scholarly journals The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial

2019 ◽  
Vol 108 ◽  
pp. 69-77 ◽  
Author(s):  
Georg A. Bjarnason ◽  
Jennifer J. Knox ◽  
Christian K. Kollmannsberger ◽  
Denis Soulieres ◽  
D. Scott Ernst ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Phase 2 Clinical Trial

scholarly journals SUN-LB043 Phase 2 Randomized Study of the Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients with Hypogonadism

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Yuliya Tishova ◽  
Ruslan Zukov ◽  
Pavel Borisov ◽  
Anastasia Bondarenko ◽  
Kristina Zakurdaeva ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Randomized Study ◽  
Phase 2 ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document